Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Why Is Wix.com (WIX) Down 11.8% Since Last Earnings Report?
Why Is Wix.com (WIX) Down 11.8% Since Last Earnings Report?

A month has gone by since the last earnings report for Wix.com (WIX). Shares have lost about 11.8% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the

Veeva (VEEV) Down 11.3% Since Last Earnings Report: Can It Rebound?
Veeva (VEEV) Down 11.3% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Veeva Systems (VEEV). Shares have lost about 11.3% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue

Okta (OKTA) Up 0.7% Since Last Earnings Report: Can It Continue?
Okta (OKTA) Up 0.7% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Okta (OKTA). Shares have added about 0.7% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the

Why Is Rigetti Computing (RGTI) Down 16.4% Since Last Earnings Report?
Why Is Rigetti Computing (RGTI) Down 16.4% Since Last Earnings Report?

It has been about a month since the last earnings report for Rigetti Computing, Inc. (RGTI). Shares have lost about 16.4% in that time frame, underperforming the S&P 500.

Will the recent negative

National Vision (EYE) Down 18.5% Since Last Earnings Report: Can It Rebound?
National Vision (EYE) Down 18.5% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for National Vision (EYE). Shares have lost about 18.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue

Why Is Keros Therapeutics (KROS) Up 2.5% Since Last Earnings Report?
Why Is Keros Therapeutics (KROS) Up 2.5% Since Last Earnings Report?

A month has gone by since the last earnings report for Keros Therapeutics, Inc. (KROS). Shares have added about 2.5% in that time frame, outperforming the S&P 500.

But investors have to be

Why Is Grocery Outlet (GO) Up 13.9% Since Last Earnings Report?
Why Is Grocery Outlet (GO) Up 13.9% Since Last Earnings Report?

A month has gone by since the last earnings report for Grocery Outlet Holding Corp. (GO). Shares have added about 13.9% in that time frame, outperforming the S&P 500.

But investors have to be

Ocugen (OCGN) Up 2.9% Since Last Earnings Report: Can It Continue?
Ocugen (OCGN) Up 2.9% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Ocugen (OCGN). Shares have added about 2.9% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue

Why Is Bath & Body Works (BBWI) Down 16.7% Since Last Earnings Report?
Why Is Bath & Body Works (BBWI) Down 16.7% Since Last Earnings Report?

A month has gone by since the last earnings report for Bath & Body Works (BBWI). Shares have lost about 16.7% in that time frame, underperforming the S&P 500.

But investors have to be wondering

Why Is Dycom Industries (DY) Down 5.9% Since Last Earnings Report?
Why Is Dycom Industries (DY) Down 5.9% Since Last Earnings Report?

It has been about a month since the last earnings report for Dycom Industries (DY). Shares have lost about 5.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend

Why Is Cracker Barrel (CBRL) Down 7% Since Last Earnings Report?
Why Is Cracker Barrel (CBRL) Down 7% Since Last Earnings Report?

A month has gone by since the last earnings report for Cracker Barrel Old Country Store (CBRL). Shares have lost about 7% in that time frame, underperforming the S&P 500.

Will the recent negative

Why Is Brown-Forman B (BF.B) Up 2.4% Since Last Earnings Report?
Why Is Brown-Forman B (BF.B) Up 2.4% Since Last Earnings Report?

A month has gone by since the last earnings report for Brown-Forman B (BF.B). Shares have added about 2.4% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the

Broadcom Inc. (AVGO) Down 5.5% Since Last Earnings Report: Can It Rebound?
Broadcom Inc. (AVGO) Down 5.5% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Broadcom Inc. (AVGO). Shares have lost about 5.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue

Abercrombie (ANF) Up 4.4% Since Last Earnings Report: Can It Continue?
Abercrombie (ANF) Up 4.4% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Abercrombie & Fitch (ANF). Shares have added about 4.4% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will

American Eagle (AEO) Down 12.9% Since Last Earnings Report: Can It Rebound?
American Eagle (AEO) Down 12.9% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for American Eagle Outfitters (AEO). Shares have lost about 12.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend

How Much Upside is Left in Abercrombie (ANF)? Wall Street Analysts Think 29.54%
How Much Upside is Left in Abercrombie (ANF)? Wall Street Analysts Think 29.54%

Abercrombie & Fitch (ANF) closed the last trading session at $92.25, gaining 4.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Think Chewy (CHWY) Could Surge 56.94%: Read This Before Placing a Bet
Wall Street Analysts Think Chewy (CHWY) Could Surge 56.94%: Read This Before Placing a Bet

Shares of Chewy (CHWY) have gained 3.1% over the past four weeks to close the last trading session at $26.87, but there could still be a solid upside left in the stock if short-term price targets of

Wall Street Analysts Predict an 113.34% Upside in Avalo Therapeutics (AVTX): Here's  What You Should Know
Wall Street Analysts Predict an 113.34% Upside in Avalo Therapeutics (AVTX): Here's What You Should Know

Shares of Avalo Therapeutics, Inc. (AVTX) have gained 1% over the past four weeks to close the last trading session at $17.76, but there could still be a solid upside left in the stock if short-term

Does Liquidia Corporation (LQDA) Have the Potential to Rally 34.47% as Wall Street Analysts Expect?
Does Liquidia Corporation (LQDA) Have the Potential to Rally 34.47% as Wall Street Analysts Expect?

Liquidia Corporation (LQDA) closed the last trading session at $37.68, gaining 9.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Predict a 46.25% Upside in Riley Exploration Permian (REPX): Here's  What You Should KnowPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Wall Street Analysts Predict a 46.25% Upside in Riley Exploration Permian (REPX): Here's What You Should Know

Riley Exploration Permian, Inc. (REPX) closed the last trading session at $36.58, gaining 12.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts Believe Spruce Biosciences (SPRB) Could Rally 181.21%: Here's is How to Trade
Wall Street Analysts Believe Spruce Biosciences (SPRB) Could Rally 181.21%: Here's is How to Trade

Spruce Biosciences, Inc. (SPRB) closed the last trading session at $70.5, gaining 31.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Chicago Atlantic Real Estate Finance (REFI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Chicago Atlantic Real Estate Finance (REFI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

The price trend for Chicago Atlantic Real Estate Finance, Inc. (REFI) has been bearish lately and the stock has lost 7.7% over the past week. However, the formation of a hammer chart pattern in its

Here's Why Sensata (ST) is a Strong Momentum Stock
Here's Why Sensata (ST) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Here's Why VALE S.A. (VALE) is a Strong Momentum Stock
Here's Why VALE S.A. (VALE) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Why Agenus (AGEN) is a Top Momentum Stock for the Long-Term
Why Agenus (AGEN) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different